Back to GetFilings.com



 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 10-Q

 

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2002

 

 

o

TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                             to

 

 

Commission File Number: 1-12624

 

 

Syratech Corporation

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

13-3354944

(State or other jurisdiction
of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

175 McClellan Highway
East Boston, Massachusetts

 

02128-9114

(Address of  principal executive office)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code - 617-561-2200

 

Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  o  NO  ý

 

Number of Shares of Common Stock, Par Value $0.01 per share, outstanding at June 30, 2002 - 3,784,018

 



 

INDEX

 

PART I - FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

 Financial Statements:

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets at June 30, 2002 and December 31, 2001

 

 

 

 

 

 

 

Condensed Consolidated Income Statements for the three and six month periods ended June 30, 2002 and 2001

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the six month periods ended June 30, 2002 and 2001

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

 

 

 

Signature

 

 

 

 

 

 

 



 

PART 1 - FINANCIAL INFORMATION

 

ITEM 1. Financial Statements

 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in thousands, except share data)

 

 

 

June 30,
2002

 

December 31,
2001

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and equivalents

 

$

1,206

 

$

5,242

 

Accounts receivable, net

 

30,183

 

57,530

 

Inventories

 

94,479

 

74,949

 

Deferred income taxes

 

22,436

 

17,848

 

Prepaid expenses and other

 

4,357

 

2,665

 

Total current assets

 

152,661

 

158,234

 

 

 

 

 

 

 

Property, plant and equipment, net

 

65,863

 

68,195

 

Purchase price in excess of net assets acquired, net

 

 

6,225

 

Other assets, net

 

4,344

 

4,717

 

Total

 

$

222,868

 

$

237,371

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Revolving loan facilities and notes payable

 

$

28,345

 

$

16,995

 

Accounts payable

 

12,449

 

10,976

 

Accrued expenses

 

6,366

 

8,079

 

Accrued interest

 

3,495

 

4,359

 

Accrued compensation

 

1,881

 

4,181

 

Accrued advertising

 

2,548

 

3,263

 

Income taxes payable

 

411

 

129

 

Total current liabilities

 

55,495

 

47,982

 

 

 

 

 

 

 

Long - term debt

 

155,052

 

157,634

 

Deferred income taxes

 

18,818

 

18,818

 

Pension liability

 

2,320

 

2,809

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $.01 par value, 500,000 shares authorized; (25,000 designated as cumulative redeemable preferred stock, 18,000 shares issued and outstanding, liquidation value of $18,000, and includes accrued and unpaid dividends of $14,574 and $12,731 in 2002 and 2001, respectively) 

 

32,574

 

30,731

 

Common stock, $.01 par value, 20,000,000 shares authorized; 3,784,018  shares issued and outstanding

 

38

 

38

 

Deficit

 

(40,183

)

(19,092

)

Accumulated other comprehensive loss

 

(1,246

)

(1,549

)

Total stockholders’ equity

 

(8,817

)

10,128

 

Total

 

$

222,868

 

$

237,371

 

 

See notes to consolidated financial statements.

 

1



 

SYRATECH CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share data)

 

 

 

Three Months
Ended June 30,

 

Six Months
Ended June 30,

 

 

 

2002

 

2001

 

2002

 

2001

 

Net sales

 

$

40,761

 

$

40,570

 

$

80,702

 

$

82,277

 

Cost of sales

 

29,186

 

28,322

 

57,934

 

60,216

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

11,575

 

12,248

 

22,768

 

22,061

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses 

 

15,607

 

15,565

 

31,017

 

31,816

 

Other operating income

 

 

332

 

 

776

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(4,032

)

(2,985

)

(8,249

)

(8,979

)

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(5,028

)

(5,372

)

(10,086

)

(10,718

)

Interest income

 

 

2

 

 

6